Benzodiazepine deprescribing

Exposure

1 paper1 finding

  • 1 lab in 1 country
  • Humans1

Outcomes

1

Mortality

no changein humans1HR 0.97

1 study
  1. Benzodiazepine deprescribing has no effect on mortality in humans (HR 0.97, 95% CI 0.68-1.39).

    “Conversely, patients in whom BZDs were deprescribed during hospitalization (n = 179) exhibited a similar mortality risk as nonusers (HR: 0.97; 95% CI: 0.68-1.39).”

    Humans6 months

    Benzodiazepine exposure and 6-month mortality in older adults post-hospitalization: time to consider deprescribing?

    The journals of gerontology. Series A, Biological sciences and medical sciences24 Nov 2025

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months